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Abstract
The aims of the present study were to investigate regional cerebral blood flow
(rCBF) in heroin-dependent patients during withdrawal and to assess the rela-
tion between these changes and duration of heroin consumption and with-
drawal data. The rCBF was measured using brain SPECT with 99mTc-
HMPAO in 16 heroin-dependent patients during heroin withdrawal. Thirteen
patients received levomethadone at the time of the SPECT scans. The images
were analyzed both visually and quantitatively. A total of 21 hypoperfused
brain regions were observed in 11 of the 16 patients. The temporal lobes were
the most affected area, hypoperfusions of the right and left temporal lobe were
observed in 5 and 5 patients, respectively. Three of the patients had a hypoper-
fusion of the right frontal lobe, 2 patients showed perfusion defects in the left
frontal lobe, right parietal lobe and left parietal lobe. The results of the quanti-
tative assessments of the rCBF were consistent with the results of the qualita-
tive findings. The stepwise regression analysis showed a significant positive
correlation (r = 0.54) between the dose of levomethadone at the time of the
SPECT scan and the rCBF of the right parietal lobe. Other significant correla-
tions between clinical data and rCBF were not found. The present results sug-
gest brain perfusion abnormalities during heroin withdrawal in heroin-depen-
dent patients, which are not due to the conditions of withdrawal.
OOOOOOOOOOOOOOOOOOOOOO
Introduction
The effect of acute and long-term heroin use and
heroin withdrawal on regional cerebral blood flow (rCBF)
is still not well understood [1]. Increase and decrease of
CBF after acute application of synthetic epodes on CBF
have been reported in animal experiments and in human
volunteers, depending on the dose application, state of the
subject (conscious or anesthetized) or brain region. How-
ever, these experiments suggest that synthetic epodes
have not a direct cerebrovascular action but that changes
of CBF are more related to metabolical, neuronal or respi-
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ratory effects of heroin receptor stimulation changes in
neuronal activity [2].
Therefore, as in other psychiatric diseases [3], investi-
gations of rCBF in subjects with a heroin dependence can
be useful in identifying areas of brain dysfunction in this
disease.
There are just a few studies exploring the changes of
the rCBF in acute and chronic heroin use [4–6]. However,
these studies have focused more on the acute effects of
opiates [4] or on the effects of opiate withdrawal on rCBF
[5, 6].
One of the purposes of our study was to measure the
CBF by HMPAO-SPECT in subjects with heroin depen-
dence who presented for detoxification in our depart-
ment. Another purpose of the present study was to figure
out whether changes in CBF were more related to the
long-term use of heroin or are more due to withdrawal
from heroin.
Methods
Subjects
Sixteen patients, 9 women and 7 men (mean age = 25.4 years,
SD = 4.3), who fulfilled DSM-III-R criteria [7] for active heroin
dependence, were included in the study. Exclusion criteria were neu-
rological signs or a history of neurological disease, head trauma, car-
diovascular or endocrinological disease, current medical illness, sero-
positive status for the human immunodeficiency virus and DSM-III-
R diagnosis of dependence on or abuse of any substance other than
heroin, nicotine or caffeine. Urine toxicology testing was used on test
days. These criteria were used to control potential confounding
effects of other substances and withdrawal from other substances.
The mean duration of heroin use was 4.0 years (SD = 3.6), the
average amount of daily street heroin was 1,046 B 633 mg/day. The
SPECT scans (n = 16) were performed during the 1st week (mean =
6.9, SD = 4.1) of detoxification. Thirteen (81.5%) patients received
levomethadone (mean dose/day: 24.1 + 21.1 mg) at the time of the
SPECT scan. The subjects received no other psychopharmacological
drug at the time of the SPECT scan. Fourteen (87.5%) patients were
right-handed, 2 patients were left-handed. Thirteen (81.2%) patients
had a CT scan. No pathological findings (e.g. tumors, infarctions,
hematomas) were found in the CT scans. The degree of opiate with-
drawal was assessed daily with the Opiate Withdrawal Scale (OWS)
[8], a self-rating scale.
Ethics
The study was approved by the Ethical Committee of the Univer-
sity of Bonn. All the patients gave their written informed consent to
participate in this study.
SPECT Technique
After giving informed consent, the patient underwent SPECT fol-
lowing intravenous injection of 20 mCi 99mTc-HMPAO. Subjects
were in a resting state, with their eyes open. The perfusion agent was
supplied by Amersham International, UK, and labeled according to
the manufacturer’s recommendation.
A rotating double-head gamma camera (Dynascan, Picker, Berea,
Ohio; full-width half-maximum = 12–15 mm) equipped with a low-
energy high-resolution parallel-hole collimator was used to obtain 64
frames with 64 ! 64 matrix within 30 min. After application of a
Metz filter and attenuation correction, activity levels in coronal, sag-
ittal, and transaxial slices parallel to the orbitomeatal line were calcu-
lated. To achieve a proper image of the temporal lobe, transversal
slices parallel to the temporal lobe plane were reconstructed [9].
For the quantitative analysis, regions of interest (ROIs) of the
same size and shape (84 pixels, 1 pixel corresponding to 6 ! 6 mm)
were drawn on 30 cerebral areas including the basal ganglia and the
cerebellum by an investigator who was unaware of the diagnosis,
visual findings and psychopathology. The ROIs were defined as fol-
lows: First, three transversal slices parallel to the orbitomeatal line
were selected, one within the basal ganglia plane, one 2.4 cm above
the basal ganglia plane, and one towards the cerebellum. In addition,
one transversal slice parallel to the temporal lobe plane was recon-
structed to display a proper image of the temporal lobe, coronal slices
were cut both through the basal ganglia and the temporal lobe, each
perpendicular to the corresponding transversal plane. Sagittal slices
were placed 1.2 cm lateral to the median slice on both sides. Anatom-
ical regions were assigned according to the anatomic atlas of Matsui
and Hirano [10].
The regional activity was calculated as follows: Frontal and occi-
pital lobe: mean of the corresponding ROI within the transversal
slice across the basal ganglia and the sagittal slice; parietal lobe: mean
of the corresponding ROI within the transversal slice 2.4 cm above
the basal ganglia plane and the sagittal slice; temporal lobe: mean of
the corresponding ROI in the transversal temporal lobe plane and the
perpendicular coronal slice across the temporal lobe; basal ganglia:
mean of the corresponding ROI of the transversal slice and the per-
pendicular coronal slice, both across the basal ganglia; cerebellum:
mean of two ROI on each side of the cerebellum (transversal plane
across the cerebellum). All values were calculated for both sides and
normalized both to the whole slice across the basal ganglia and to the
cerebellum.
The SPECT scans were analyzed qualitatively by 3 experienced
nuclear medicine specialists. Diminished perfusion (hypoperfusion)
was defined by markedly reduced tracer uptake in one or more brain
regions relative to the remaining regions as determined by 3 experi-
enced nuclear medicine specialists. Intrarater reliability was more
than 95%, and interrater reliability more than 94%.
Statistical Analysis
Mann-Whitney U tests were performed for the analyses of the
differences of clinical data as age, length of heroin dependence, dose
of daily consumed heroin, day of the SPECT study within the with-
drawal period, dose of levomethadone at the time of the SPECT
study, score on the OWS at the time of the SPECT study in the sub-
jects with and without pathological qualitative findings. Multiple
linear regression analysis was applied for the quantitative analyses to
evaluate the relationship between rCBF and clinical data. The criteri-
on for statistical significance was set at p ! 0.05 to have adequate
power to detect differences with the small number of subjects. All
data analyses were performed on a microcomputer using the SPSS/
PC+ 4.0.1 (SPSS Inc., Chicago, Ill.) statistical software.
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Fig. 1. A–D Transaxial (rotated parallel to the longitudinal axis of
the temporal lobe) images of rCBF from a 23-year-old heroin-depen-
dent woman with a 1-year history of heroin dependence who was free
of opioids for 6 days at the time of the scanning. Dark areas represent
areas with low rCBF and light areas represent areas with high rCBF.
The left side of the images corresponds to the right hemisphere. Note
the decrease of the rCBF in the medial and lateral part of the right
temporal lobe visible in 4 consecutive sections (arrows). The localiza-
tion of the 4 slices is represented in the schematic illustration below.
Table 1. Frequency of brain regions with
hypoperfusion in 16 opioid-dependent pa-
tients during first week of withdrawal
Region Right Left
Frontal 3 2
Temporal 5 5
Parietal 2 2
Occipital 1 0
Basal ganglia 1 0
Total regions with
hypoperfusion 12 9
Total patients1 7 7
1 Three patients showed hypoperfusions in
the right and left hemisphere, therefore the
number of patients with at least one patho-
logical CBF was 11.
Results
Eleven (68.7%) of the 16 heroin-dependent patients
showed at least one region with a pathological CBF pat-
tern. A total of 21 hypoperfused brain regions was ob-
served in 11 of the 16 patients. The major findings were
hypoperfusions of the right (n = 5) and left (n = 5) tempo-
ral lobe (fig. 1). Right frontal hypoperfusion was found in
3 patients, 2 patients showed hypoperfusions of the left
frontal lobe. Hypoperfusions of the right and left parietal
lobe were found in 2 patients each. The distribution of all
areas with a decreased CBF is shown in table 1.
To compare the results of visual interpretation with
those of quantitative analysis, two groups with pathologi-
cal versus normal rCBF patterns were formed for the
brain areas in which hypoperfusion was most commonly
found (left and right temporal lobe).
Statistical analysis with the Mann-Whitney U test
revealed significant differences between the rCBF in pa-
tients with visually determined hypoperfusion and those
with visually determined normal blood flow for the ana-
lyzed regions. The mean B SD values for the hypoper-
fused areas were: left temporal 1.05 B 0.07, right tempo-
ral 1.12 B 0.06. The corresponding values for normal
flow were: left temporal 1.16 B 0.07, right temporal 1.21
B 0.09.
Stepwise regression analysis was then performed to
analyze possible relationships between rCBF and age,
length of heroin dependence, dose of daily consumed
heroin, day of the SPECT study within the withdrawal
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period, dose of levomethadone at the time of the SPECT
study, score on the OWS at the time of the SPECT study.
The stepwise regression analysis showed a significant
positive correlation (r = 0.54) between the dose of levo-
methadone on the day of the SPECT study and rCBF of
the right parietal lobe (analysis of variance: F = 6.02, d.f. =
1, p = 0.02). All other correlations did not reach a signifi-
cance level. Especially, there was no significant correla-
tion between the self-ratings measured with the OWS and
the rCBF.
Discussion
In this study, we used HMPAO-SPECT to measure
rCBF in patients with heroin dependence during the first
days of withdrawal.
The findings from this study can be summarized as fol-
lows: (1) the majority (n = 11, 68.7%) of the 16 heroin-
dependent patients showed a pathological CBF during
withdrawal. A total of 21 hypoperfused brain regions were
observed; (2) the most affected brain areas were the right
(n = 5) and left (n = 5) temporal lobes and the right (n = 3)
and left (n = 2) parietal lobes, and (3) the quantitative
assessments of hypoperfusion of the right parietal lobe
correlated with the dose of levomethadone on the day of
the SPECT study; other significant correlations were not
found between rCBF heroin abuse history or withdrawal
data.
The results of the present study should be interpreted
in the context of some potentially important methodologi-
cal limitations. One bias of our study is the absence of a
control group. However, (1) we used an intraindividual
paradigm for our assessments by comparing all defined
regions of one hemisphere with the same regions of the
other hemisphere, and (2) the qualitative assessments
were supported by the quantitative data.
Another possible limitation is the use of qualitative
data. Despite the great value of quantification in modern
nuclear medicine techniques, visual interpretation of
images is known to be a valuable tool. The relative
decrease of mean values in the temporal lobes was 9.5%
(left temporal lobe), and 7.4% (right temporal lobe).
These values agree well with the approximate 10% limit
defining hypoperfusion which is commonly practiced in
many SPECT laboratories and is also used by us. The lim-
it defining hypoperfusion in qualitative assessments is
approximately 10%. Furthermore, in a study by Heiss et
al. [11], it was concluded that the results assessed with the
SPECT technique can be compared with the results of
PET studies. A recent study has shown that volumetric
analysis of regional hypoperfusion on SPECT/HMPAO-
SPECT is highly accurate and reproducible [12].
Another possible limitation of our results is that the
decrease of metabolism in the temporal lobes may reflect
the level of anxiety of the patients at the time of the scans.
The results of SPECT studies and PET studies reporting
relationships between anxiety and CBF are inconclusive.
In the study by O’Caroll et al. [13], reductions of the rCBF
were reported in right temporal lobe and occipital regions
in patients suffering from phobia after anxiety induction.
However, in the study by Mountz et al. [14], no relation-
ship was found between anxiety and cerebral blood flow.
Mathew and Wilson [15] concluded in their review article
on anxiety and CBF that the effect of acute anxiety on
CBF is highly complex and associated with a number of
factors such as arousal, sympathetic tone, CO2, etc.
Another limitation of the study is that the majority (n =
13) of the subjects received levomethadone at the time of
the SPECT study. However, Levin et al. [16] found that
abnormal rCBF after detoxification was improved in
their HMPAO-SPECT study on heroin-dependent poly-
drug abusers in a dose-related manner by treatment with
buprenorphine. Furthermore, in our study we found a
hypoperfusion of the parietal lobe in the opiate addicts
and also a positive significant correlation between the
rCBF in the right parietal lobe and the dose of levome-
thadone. This means that treatment with levomethadone
rather improved the pathological rCBF in the parietal
lobe. Therefore, it does not appear plausible that observed
pathological rCBF findings were due to the levometha-
done treatment.
What pathophysiological mechanisms are responsible
for the observed decreases in the rCBF of different brain
regions in heroin-dependent patients? There are several
possible explanations. One possibility is that the observed
pathological findings are due to the heroin withdrawal
state. This would mean that the pathological findings are
reversible after the termination of the withdrawal. In our
study, we found a significant negative correlation between
quantitative rCBF of the right parietal lobe and dose of
levomethadone at the time of the SPECT scan. Similar
results were obtained in a study of Rose et al. [6]. In their
first scan 1 week after discontinuation of the medication
with clonidine, 9 of the 10 subjects demonstrated signifi-
cant perfusion defects in the frontal parietal and temporal
cortices, however, in the repeat scan 2 weeks later all 9
subjects with former pathological findings showed an
improvement of the abnormal scans.
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Our results are also consistent with findings of an
abnormal cerebral metabolism in heroin-dependent pa-
tients measured by 31P MR spectroscopy [17]. However,
in this study, the subjects also met DSM-III-R criteria for
a concurrent cocaine dependence. Therefore it is not clear
whether the described pathological results are not due to
the cocaine dependence.
In the study by Krystal et al. [5], naloxone was admin-
istered in 10 methadone-maintained patients and the
changes of the rCBF were measured by HMPAO-SPECT.
Opiate-dependent patients, but not healthy subjects, de-
veloped opiate withdrawal signs. In this study, a signifi-
cant reduction in ratios activities in the frontal and pari-
etal cortices were observed in the patients who developed
withdrawal signs. However, the methadone-maintained
patients showed also a pathological blood flow even if
they did not receive naloxone. In addition, in the study of
Rose et al. [6], abnormal scans were obtained after 1 week
of drug discontinuation when all symptoms of withdrawal
had subsided.
Therefore, another mechanism that could account for
the pathological SPECT scans in our study includes a
direct effect of heroin on rCBF. The acute effects of
opiates on human cerebral metabolism have been de-
scribed in a study by London et al. [4]. In their study, 30
mg of morphine given intramuscularly produced reduced
glucose utilization by 10% in the whole brain and by
about 5–15% in the telencephalic areas of the cerebellar
cortex. A reduction of the cerebral glucose metabolism
was also observed after administration of 1 mg buprenor-
phine in polydrug abusers [18]. An opioid-induced de-
crease of the CBF has been described in previous studies
in animals and humans [2, 19].
However, in these studies the distribution and degree
of decreases of rCBF were not correlated with the distri-
bution of opioid receptors in human brain [20], suggesting
a rather complex association between opioids and CBF or
glucose utilization respectively.
However, little information is available on the long-
term effects of opiates on CBF and cerebral metabolism
[1]. Brust and Richter [21] reported on strokes associated
with addiction to heroin. However, in these reported
cases, different etiologic factors, including loss of con-
sciousness following after an overdose of heroin, intrace-
rebral hemorrhage, cerebral embolization or vessel arteri-
tis were implicated.
A third explanation is that the observed hypoperfu-
sions in the temporal and parietal lobes were due to struc-
tural brain changes. This includes also secondary effects
of drug abuse as long-term nutritional deficiencies, trau-
matic injuries of the head, infections of the central ner-
vous system, repeated anoxic states or cerebral metabo-
lism disturbances due to liver diseases. There are reports
which revealed structural brain changes in heroin addicts
[22, 23]. Experimental studies have shown that endoge-
nous opioids [24] and morphine [25] interact with mecha-
nisms which control neural growth, findings which may
be relevant to the long-term effects of chronic use of
opioids in humans. However, other CT and MRI studies
did not replicate pathological morphological findings in
opioid dependents [26, 27].
However, in the present study, the lack of pathological
findings on CT examinations does not support this hy-
pothesis. Furthermore, we did not find any significant
correlation between the duration of heroin use, dose of
daily consumed heroin and the qualitative or quantitative
SPECT findings. In addition, the pathological findings in
the study of Rose et al. [6] were reversible in the repeat
scan 2 weeks later.
The localization of the decreases in the temporal lobes
in our study are consistent with the findings of other stud-
ies which investigated the effects of opioids on glucose uti-
lization, or CBF. London et al. [4] found significant
decreases of regional cerebral metabolic rates for glucose
in the temporal cortical regions after the administration
of morphine. A decrease of rCBF in temporal areas was
observed after administration of fentanyl [17].
In the studies of Krystal et al. [5] and Rose et al. [6], the
pathological findings were located in the frontal and pari-
etal lobes. In the study of Rose et al. [6] pathological find-
ings were also found in the temporal lobe. In the present
study the most affected brain region was the temporal
lobe. These discrepancies between our study and the cited
studies could be due to differences in the SPECT tech-
nique: The transaxial sections were cut parallel to the lon-
gitudinal axis of the temporal lobe [9]. Previous SPECT
studies in psychiatric patients [13, 28] chose ROIs located
only on sections parallel to the cantomeathal line. We
think that with our method we can measure the rCBF in
the temporal lobe more precisely than in previous stud-
ies.
The observed positive correlation between the dose of
levomethadone on the day of the SPECT study and rCBF
in the right parietal lobe is partly consistent with findings
in the study of Krystal et al. [5]. In this HMPAO-SPECT
study, administration of naloxone, an opioid antagonist,
in healthy subjects was associated with decreased right
parietal cortex activity ratios. Therefore, hypoperfusion
in the right parietal region seems to be associated with
withdrawal-dependent factors.
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In conclusion, the present results are consistent with
previous findings of pathological CBF in opiate with-
drawal. The distribution of affected brain regions is not
closely associated with the distribution of opioid recep-
tors in human brain. These pathological findings appear
also not to be mainly due to the withdrawal status.
As alterations of rCBF in other psychiatric diseases,
the pathophysiological mechanisms that underlie rCBF
disturbances in opiate dependence are complex and still
little understood.
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